Literature DB >> 15295413

Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease.

R Parkash1, R A deKemp, T D Ruddy, A Kitsikis, R Hart, L Beauchesne, L Beauschene, Kathryn Williams, R A Davies, M Labinaz, R S B Beanlands.   

Abstract

BACKGROUND: Standard perfusion imaging may underestimate the extent of disease in 3-vessel coronary atherosclerosis. This study determined whether positron emission tomography quantification of perfusion reserve by use of rubidium 82 net retention defined a greater extent of disease than the standard approach in patients with 3-vessel disease. METHODS AND
RESULTS: Rb-82 net retention was quantified as an estimation of absolute perfusion at rest and with dipyridamole stress by use of dynamic positron emission tomography imaging. The percent of abnormal myocardial sectors, as compared with a normal database, for a standard and quantification approach was determined. Twenty-three patients were evaluated. Defect sizes were larger in patients with 3-vessel disease (n = 13) by use of quantification methods: 44% +/- 18% of the myocardial sectors were abnormal by use of the standard approach versus 69% +/- 24% of sectors when measured by quantification of the stress-rest perfusion difference (P =.008). In patients with single-vessel disease (n = 10), defect sizes were smaller with quantification methods.
CONCLUSIONS: Quantification of Rb-82 net retention to measure the stress-rest perfusion difference in the myocardium defined a greater extent of disease than the standard approach in this group of patients with triple-vessel disease. More accurate measurement of the extent of coronary artery disease could facilitate better risk stratification and identify more high-risk patients in whom aggressive intervention is required.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15295413     DOI: 10.1016/j.nuclcard.2004.04.005

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  44 in total

1.  Automated determination of the left ventricular long axis in cardiac positron tomography.

Authors:  R A deKemp; C Nahmias
Journal:  Physiol Meas       Date:  1996-05       Impact factor: 2.833

2.  Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging.

Authors:  G D Hutchins; M Schwaiger; K C Rosenspire; J Krivokapich; H Schelbert; D E Kuhl
Journal:  J Am Coll Cardiol       Date:  1990-04       Impact factor: 24.094

3.  Assessment of coronary artery disease severity by positron emission tomography. Comparison with quantitative arteriography in 193 patients.

Authors:  L L Demer; K L Gould; R A Goldstein; R L Kirkeeide; N A Mullani; R W Smalling; A Nishikawa; M E Merhige
Journal:  Circulation       Date:  1989-04       Impact factor: 29.690

4.  Hyperglycemia rather than insulin resistance is related to reduced coronary flow reserve in NIDDM.

Authors:  I Yokoyama; T Ohtake; S Momomura; K Yonekura; S Woo-Soo; J Nishikawa; Y Sasaki; M Omata
Journal:  Diabetes       Date:  1998-01       Impact factor: 9.461

5.  Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen 13 ammonia-labeled positron emission tomography.

Authors:  S Sawada; O Muzik; R S Beanlands; E Wolfe; G D Hutchins; M Schwaiger
Journal:  J Nucl Cardiol       Date:  1995 Sep-Oct       Impact factor: 5.952

6.  Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study.

Authors:  D S Berman; H Kiat; J D Friedman; F P Wang; K van Train; L Matzer; J Maddahi; G Germano
Journal:  J Am Coll Cardiol       Date:  1993-11-01       Impact factor: 24.094

7.  A quantitative index of regional blood flow in canine myocardium derived noninvasively with N-13 ammonia and dynamic positron emission tomography.

Authors:  C A Nienaber; O Ratib; S S Gambhir; J Krivokapich; S C Huang; M E Phelps; H R Schelbert
Journal:  J Am Coll Cardiol       Date:  1991-01       Impact factor: 24.094

8.  A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET.

Authors:  Y Choi; S C Huang; R A Hawkins; W G Kuhle; M Dahlbom; C K Hoh; J Czernin; M E Phelps; H R Schelbert
Journal:  J Nucl Med       Date:  1993-03       Impact factor: 10.057

9.  Quantification of regional myocardial blood flow in vivo with H215O.

Authors:  S R Bergmann; K A Fox; A L Rand; K D McElvany; M J Welch; J Markham; B E Sobel
Journal:  Circulation       Date:  1984-10       Impact factor: 29.690

10.  Early impairment of coronary flow reserve in young men with borderline hypertension.

Authors:  H Laine; O T Raitakari; H Niinikoski; O P Pitkänen; H Iida; J Viikari; P Nuutila; J Knuuti
Journal:  J Am Coll Cardiol       Date:  1998-07       Impact factor: 24.094

View more
  91 in total

1.  Combining dynamic and ECG-gated ⁸²Rb-PET for practical implementation in the clinic.

Authors:  George A Sayre; Stephen L Bacharach; Michael W Dae; Youngho Seo
Journal:  Nucl Med Commun       Date:  2012-01       Impact factor: 1.690

2.  Ischemic changes on rubidium-82 positron emission tomography imaging are associated with left ventricular functional and volumetric change independent of metabolic properties and echocardiographic functional variables in ischemic cardiomyopathy.

Authors:  Raymond C Wong; Manuel D Cerqueira; Richard C Brunken
Journal:  Int J Cardiovasc Imaging       Date:  2011-11-11       Impact factor: 2.357

Review 3.  PET: Is myocardial flow quantification a clinical reality?

Authors:  Antti Saraste; Sami Kajander; Chunlei Han; Sergey V Nesterov; Juhani Knuuti
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

4.  Novel and simple carbon-11-labeled ammonium salts as PET agents for myocardial perfusion imaging.

Authors:  Ohad Ilovich; Hana Billauer; Sharon Dotan; Nanette M T Freedman; Moshe Bocher; Eyal Mishani
Journal:  Mol Imaging Biol       Date:  2011-02       Impact factor: 3.488

5.  Intra- and inter-operator repeatability of myocardial blood flow and myocardial flow reserve measurements using rubidium-82 pet and a highly automated analysis program.

Authors:  Ran Klein; Jennifer M Renaud; Maria C Ziadi; Stephanie L Thorn; Andy Adler; Rob S Beanlands; Robert A deKemp
Journal:  J Nucl Cardiol       Date:  2010-04-13       Impact factor: 5.952

Review 6.  The clinical utility of assessing myocardial blood flow using positron emission tomography.

Authors:  Maria Cecilia Ziadi; Rob S B Beanlands
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

7.  Coronary flow reserve by CT perfusion.

Authors:  Richard T George; Frank M Bengel; Albert C Lardo
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

Review 8.  Quantification of myocardial blood flow and flow reserve: Technical aspects.

Authors:  Ran Klein; Rob S B Beanlands; Robert A deKemp
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

9.  Novel F-18-labeled PET myocardial perfusion tracers: bench to bedside.

Authors:  Stephan G Nekolla; Antti Saraste
Journal:  Curr Cardiol Rep       Date:  2011-04       Impact factor: 2.931

Review 10.  Left main coronary artery disease: A review of the spectrum of noninvasive diagnostic modalities.

Authors:  Nishtha Sareen; Karthik Ananthasubramaniam
Journal:  J Nucl Cardiol       Date:  2015-10-20       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.